Pharmacokinetics of enoxaparin in COVID-19 critically ill patients

BACKGROUND: In intensive-care unit (ICU) patients, pathophysiological changes may affect the pharmacokinetics of enoxaparin and result in underdosing. OBJECTIVES: To develop a pharmacokinetic model of enoxaparin to predict the time-exposure profiles of various thromboprophylactic regimens in COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Zufferey, Paul Jacques, Dupont, Annabelle, Lanoiselée, Julien, Bauters, Anne, Poissy, Julien, Goutay, Julien, Jean, Laurent, Caplan, Morgan, Levy, Lionel, Susen, Sophie, Delavenne, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294601/
https://www.ncbi.nlm.nih.gov/pubmed/34311154
http://dx.doi.org/10.1016/j.thromres.2021.07.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294601/
https://www.ncbi.nlm.nih.gov/pubmed/34311154
http://dx.doi.org/10.1016/j.thromres.2021.07.010

Ejemplares similares